Rimonabant

Products Rimonabant was on the market in the form of film-coated tablets (Acomplia, Zimulti) starting in 2006. Because the drug can cause psychiatric disorders such as depression as a side effect, it was withdrawn from the market in 2008. Structure and properties Rimonabant (C22H21Cl3N4O, Mr = 463.8 g/mol) is a chlorinated piperidine and pyrazole carboxamide … Rimonabant

Market Withdrawal of Drugs

Why is the distribution of medicines discontinued? Drugs are subject to a product life cycle. They are discovered, patented, developed, approved, marketed and, in some circumstances, withdrawn from the market years to decades later. Often, distribution is discontinued due to commercial considerations. For example, the cost of approval and production exceeds the revenue from sales. … Market Withdrawal of Drugs